Search Results

Requesting GP Prescribing SOP (S147)

To enable non-prescribing clinicians access to an internal group of DCHS prescribers to ensure patients receive clinically indicated medicines in a timely way without putting undue pressure on Community GPs within the system.

Accessible Information and Communication policy

L230 - Welcome to North Derbyshire Pulmonary Rehabilitation

L230 - Welcome to North Derbyshire Pulmonary Rehabilitation leaflet

SOP for the supply or issue of Steroid Emergency Cards (S87)

Identify / supply to patients who require a Steroid Emergency card in the Community Hospitals setting, Urgent Treatment Centres, Podiatric Surgery, Integrated Community teams and specialist services such as Respiratory teams and Physiotherapy if a new Steroid Emergency card is needed or a Steroid Emergency Card has been lost

A4 - List of CDs which Require Denaturing and Witnessed Destruction (S47)

Appendix 4 - List of CDs which Require Denaturing and Witnessed Destruction (S47)

Podiatry Service Changes FAQs .docx

DCHS Podiatry Service Changes FAQs

Disclosure Ref 202262 - Ethnic minority categories used for patients.pdf

FOI Disclosure

Midazolam by Buccal Administration for Children (UTC)

PGD Midazolam by Buccal Administration for Children (UTC)

Guidance Checklist to Support Clinicians in determining Fast Track Eligibility (G258)

This guidance has been developed to assist Clinicians to determine whether it is appropriate to complete the Fast Track - Continuing Healthcare Application. The intention of the Fast Track Pathway is that it should identify individuals who need to access NHS Continuing Healthcare (CHC) quickly, with minimum delay, and with no requirement to complete a CHC Decision Support Tool (DST). Therefore, the completed Fast Track Pathway Tool, with clear reasons why the individual fulfils the criteria, and which clearly evidences that an individual is both rapidly deteriorating and approaching the end of life.

Disclosure Ref 2022127 - BI & Data Warehousing, E-rostering, Order Communications, Pathology, Pharmacy, & Scheduling.pdf

Response to FOI